News
A new study presented at the European Respiratory Society Conference in Vienna suggests that popular epilepsy drug Sulthiame may reduce major Obstructive Sleep Apnea (OSA) symptoms. According to ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
Hosted on MSN7mon
Drug treatment shows promise for dangerous snoring condition, obstructive sleep apneaPatients taking sulthiame, a drug currently in use for epilepsy, experienced a reduction in their symptoms of obstructive sleep apnea (OSA ... and they may wake up several times.
A popular obesity drug may help treat a dangerous disorder ... also the diabetes treatment Mounjaro, appeared to reduce the severity of sleep apnea along with reducing weight and improving blood ...
Apnimed’s approach to obstructive sleep ... reduce [apnea-hypopnea index] in one pharmaceutical formulation, we believe IHL-42X may have therapeutic benefit at lower doses of each constituent ...
2mon
WNEM Saginaw on MSNMedical milestone: First drug for sleep apneaFinally, there may be another option for Roger — a drug ... sleep apnea because of the weight loss, or does it change brain ...
Hosted on MSN1mon
FDA approves weight-loss drug Zepbound for obstructive sleep apneaThe U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound. The medicine, part of the class known as GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results